Abstract
A brief therapeutic regimen of praziquantel, reduced to a single day, has been effective for treatment of neurocysticercosis. To study its pharmacokinetic characteristics, levels of praziquantel in plasma were determined for eight healthy volunteers after the administration of three oral doses of 25 mg/kg of body weight given at 2-h intervals, alone and with the simultaneous administration of cimetidine. Each volunteer received both regimens in a randomized crossover design. Blood samples were taken during a period of 12 h, and praziquantel concentration was measured by high-performance liquid chromatography. Levels of praziquantel in plasma remained above 300 ng/ml during a period of 12 h; they increased 100% when cimetidine was jointly administered. Compared with other regimens, the high levels obtained and the longer duration of action seem to be advantageous in prolonging the exposure of the parasites to the drug and support previous clinical experience showing that the treatment of neurocysticercosis with praziquantel can be reduced from 2 weeks to 1 day with the drug still retaining its cysticidal properties. Moreover, simultaneous administration of praziquantel and cimetidine could improve further the efficacy of the sin...Continue Reading
References
Dec 1, 1978·European Journal of Clinical Pharmacology·G LeopoldD H Wegner
Sep 3, 1992·The New England Journal of Medicine·V Vazquez, J Sotelo
May 1, 1990·Transactions of the Royal Society of Tropical Medicine and Hygiene·M E MandourD W Harron
Apr 1, 1990·Journal of Neurology·J SoteloF Rubio-Donnadieu
Jan 1, 1990·European Neurology·P R BittencourtT V Oliveira
Aug 1, 1990·Journal of Neurology·H JungJ Sotelo
Jul 1, 1990·Acta Neurologica Scandinavica·P R BittencourtT V Oliveira
Dec 1, 1990·Clinical Neuropharmacology·H JungJ Sotelo
Feb 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·B EstañolT Corona
Sep 6, 1986·Lancet·G WattJ H Cross
Sep 1, 1987·Neurology·M L VazquezJ Sotelo
Jan 1, 1987·European Journal of Clinical Pharmacology·D OverboschH Mattie
Apr 19, 1984·The New England Journal of Medicine·J SoteloF Rubio-Donnadieu
Sep 18, 1993·Lancet·A FlisserE Sarti
Mar 1, 1994·The Journal of Infectious Diseases·W D DachmanM Winograd
Mar 5, 1993·Journal of Chromatography·D F González-EsquivelH J Cook
Jan 11, 1996·The New England Journal of Medicine·T CoronaJ Sotelo
Citations
May 31, 2003·CNS Drugs·Terrence Riley, A C White
Jul 29, 2010·Nanomedicine·Shuyu XieWenZhong Zhou
Apr 7, 2006·Expert Review of Anti-infective Therapy·Michael J Doenhoff, Livia Pica-Mattoccia
Dec 7, 2011·Expert Review of Clinical Pharmacology·Helgi Jung-Cook
Nov 16, 2011·Expert Opinion on Pharmacotherapy·Osvaldo Massaiti TakayanaguiVera Lucia Lanchote
May 16, 2019·European Journal of Clinical Pharmacology·Lovejoy NleyaCollen Masimirembwa
Mar 29, 2003·American Journal of Veterinary Research·Elliott R JacobsonEric J Laille
Sep 14, 2001·Journal of Veterinary Pharmacology and Therapeutics·M GiorgiG Mengozzi
Sep 28, 2018·Current Medicinal Chemistry·Charlotte M Thomas, David J Timson
Jun 12, 2019·Journal of Veterinary Pharmacology and Therapeutics·Zeynep OzdemirBunyamin Tras
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Nelly CastroJulio Sotelo
Oct 17, 2016·Clinical Pharmacokinetics·Luka Verrest, Thomas P C Dorlo
Jul 24, 2020·Pharmacology Research & Perspectives·Nyasha Nicole KapunguRoslyn Stella Thelingwani
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·N CastroH Jung
Dec 12, 2018·Clinical and Translational Science·Wilhelmina Maria BagchusOezkan Yalkinoglu
Sep 26, 2020·PLoS Neglected Tropical Diseases·Grace Zdesenko, Francisca Mutapi